The complex effects of leptin on bone metabolism through multiple pathways

Current Opinion in Pharmacology

Volumn 4, Issue 3, 2004, Pages 295-300

  Thomas, Thierry ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; LEPTIN; NEUROPEPTIDE Y; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

ADRENERGIC SYSTEM; BONE DENSITY; BONE DEVELOPMENT; BONE GROWTH; BONE MATURATION; BONE METABOLISM; BONE MINERAL; BONE REMODELING; CELL DIFFERENTIATION; DRUG ACTIVITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRABECULAR BONE; VITAMIN D METABOLISM;

ANIMALS; BONE MARROW; BONE REMODELING; HUMANS; LEPTIN;

EID: 2342518168     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.01.009     Document Type: Review

References (62)

1. Spiegelman B.M. Flier J.S. Obesity and the regulation of energy balance Cell 104 2001 531-543
2. Henry B.A. Goding J.W. Alexander W.S. Tilbrook A.J. Canny B.J. Dunshea F. Rao A. Mansell A. Clarke I.J. Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: evidence for a dissociation of effects on appetite and neuroendocrine function Endocrinology 140 1999 1175-1182
3. Owen M: Lineage of osteogenic cells and their relationship to the stromal system. In Bone and Mineral Research Vol 3. Edited by Peck WA. Amsterdam: Elsevier; 1985:1-23.
4. Thomas T. Gori F. Khosla S. Jensen M.D. Burguera B. Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes Endocrinology 140 1999 1630-1638
5. Reseland J.E. Syversen U. Bakke I. Qvigstad G. Eide L.G. Hjertner O. Gordeladze J.O. Drevon C.A. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization J Bone Miner Res 16 2001 1426-1433
6. Cornish J. Callon K.E. Bava U. Lin C. Naot D. Hill B.L. Grey A.B. Broom N. Myers D.E. Nicholson G.C. Reid I.R. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo J Endocrinol 175 2002 405-415
7. Lee Y.J. Park J.H. Ju S.K. You K.H. Ko J.S. Kim H.M. Leptin receptor isoform expression in rat osteoblasts and their functional analysis FEBS Lett 528 2002 43-47
8. Takahashi Y. Okimura Y. Mizuno I. Iida K. Takahashi T. Kaji H. Abe H. Chihara K. Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells J Biol Chem 272 1997 12897-12900
9. Iwaniec U.T. Shearon C.C. Heaney R.P. Cullen D.M. Yee J.A. Leptin increases number of mineralized bone nodules in vitro Bone 23 Suppl 1988 S212
10. Bai Y. Zhang S. Kim K.S. Lee J.K. Kim K.H. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones J Biol Chem 271 1996 13939-13942
11. Lai C.F. Chaudhary L. Fausto A. Halstead L.R. Ory D.S. Avioli L.V. Cheng S.L. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells J Biol Chem 276 2001 14443-14450
12. Hu E. Kim J.B. Sarraf P. Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma Science 274 1996 2100-2103
13. Gordeladze J.O. Drevon C.A. Syversen U. Reseland J.E. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling J Cell Biochem 85 2002 825-836
14. Burguera B. Hofbauer L. Thomas T. Gori F. Lassam J. Laasko K. Evans G. Khosla S. Riggs B.L. Turner R.T. Leptin reduces ovariectomy-induced bone loss in rats Endocrinology 142 2001 3546-3553
15. Holloway W.R. Collier F.M. Aitken C.J. Myers D.E. Hodge J.M. Malakellis M. Gough T.J. Collier G.R. Nicholson G.C. Leptin inhibits osteoclast generation J Bone Miner Res 17 2002 200-209
16. Gabay C. Dreyer M. Pellegrinelli N. Chicheportiche R. Meier C.A. Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes J Clin Endocrinol Metab 86 2001 783-789
17. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG: Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92:73-8.
18. Liu C. Grossman A. Bain S. Strachan M. Puerner D. Bailey C. Humes J. Lenox J. Yamamoto G. Sprugel K. et al. Lepti stimulates cortical bone formation in obese (ob/ob) mice J Bone Miner Res 12 Suppl1 1997 S115
19. Thomas T. Martin A. de Vittoris R. Lafage-Proust M.H. Alexandre C. Vico L. Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats J Bone Miner Res 18 Suppl2 2003 S42
20. Goldstone A.P. Howard J.K. Lord G.M. Ghatei M.A. Gardiner J.V. Wang Z.L. Wang R.M. Girgis S.I. Bailey C.J. Bloom S.R. Leptin prevents the fall in plasma osteocalcin during starvation in male mice Biochem Biophys Res Commun 295 2002 475-481
21. Thomas T. Burguera B. Melton L.J. III Atkinson E.J. Riggs B.L. Khosla S. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women Bone 29 2001 114-120
22. Goulding A. Taylor R.W. Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in post-menopausal women Calcif Tissue Int 63 1998 456-458
23. Yamauchi M. Sugimoto T. Yamaguchi T. Nakaoka D. Kanzawa M. Yano S. Ozuru R. Sugishita T. Chihara K. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women Clin Endocrinol 55 2001 341-347
24. Ruhl C.E. Everhart J.E. Relationship of serum leptin concentration with bone mineral density in the United States population J Bone Miner Res 17 2002 1896-1903
25. Blain H. Vuillemin A. Guillemin F. Durant R. Hanesse B. de Talance N. Doucet B. Jeandel C. Serum leptin level is a predictor of bone mineral density in postmenopausal women J Clin Endocrinol Metab 87 2002 1030-1035
26. Zoico E. Zamboni M. Adami S. Vettor R. Mazzali G. Tosoni P. Bissoli L. Bosello O. Relationship between leptin levels and bone mineral density in the elderly Clin Endocrinol (Oxf) 59 2003 97-103
27. Pasco J.A. Henry M.J. Kotowicz M.A. Collier G.R. Ball M.J. Ugoni A.M. Nicholson G.C. Serum leptin levels are associated with bone mass in nonobese women J Clin Endocrinol Metab 86 2001 1884-1887
28. Rauch F. Blum W.F. Klein K. Allolio B. Schonau E. Does leptin have an effect on bone in adult women? Calcif Tissue Int 63 1998 453-455
29. Odabasi E. Ozata M. Turan M. Bingol N. Yonem A. Cakir B. Kutlu M. Ozdemir I.C. Plasma leptin concentrations in postmenopausal women with osteoporosis Eur J Endocrinol 142 2000 170-173
30. Martini G. Valenti R. Giovani S. Franci B. Campagna S. Nuti R. Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women Bone 28 2001 113-117
31. Ushiroyama T. Ikeda A. Hosotani T. Higashiyama T. Ueki M. Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women Gynecol Endocrinol 17 2003 31-36
32. Blum M. Harris S.S. Must A. Naumova E.N. Phillips S.M. Rand W.M. Dawson-Hughes B. Leptin, body composition and bone mineral density in premenopausal women Calcif Tissue Int 73 2003 27-32
33. Thomas T. Burguera B. Melton L.J. III Atkinson E.J. Riggs B.L. Khosla S. Relationship of serum leptin levels with body composition, sex steroid, and insulin levels in men and women Metabolism 49 2000 1278-1284
34. Roux C. Arabi A. Porcher R. Garnero P. Serum leptin as a determinant of bone resorption in healthy postmenopausal women Bone 33 2003 847-852
35. Simha V. Zerwekh J.E. Sakhaee K. Garg A. Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy J Clin Endocrinol Metab 87 2002 4942-4945
36. Xiao E. Xia-Zhang L. Vulliemoz N.R. Ferin M. Wardlaw S.L. Leptin modulates inflammatory cytokine and neuroendocrine responses to endotoxin in the primate Endocrinology 144 2003 4350-4353
37. Farooqi I.S. Matarese G. Lord G.M. Keogh J.M. Lawrence E. Agwu C. Sanna V. Jebb S.A. Perna F. Fontana S. et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency J Clin Invest 110 2002 1093-1103
38. Sierra-Honigmann M.R. Nath A.K. Murakami C. Garcia-Cardena G. Papapetropoulos A. Sessa W.C. Madge L.A. Schechner J.S. Schwabb M.B. Polverini P.J. Flores-Riveros J.R. Biological action of leptin as an angiogenic factor Science 281 1998 1683-1686
39. Kume K. Satomura K. Nishisho S. Kitaoka E. Yamanouchi K. Tobiume S. Nagayama M. Potential role of leptin in endochondral ossification J Histochem Cytochem 50 2002 159-169
40. Masuzaki H. Ogawa Y. Sagawa N. Hosoda K. Matsumoto T. Mise H. Nishimura H. Yoshimasa Y. Tanaka I. Mori T. Nakao K. Nonadipose tissue production of leptin. Leptin as a novel placenta-derived hormone in humans Nat Med 3 1997 1029-1033
41. Maor G. Rochwerger M. Segev Y. Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers J Bone Miner Res 17 2002 1034-1043
42. Nakajima R. Inada H. Koike T. Yamano T. Effects of leptin to cultured growth plate chondrocytes Horm Res 60 2003 91-98
43. Dixit V.D. Mielenz M. Taub D.D. Parvizi N. Leptin induces growth hormone secretion from peripheral blood mononuclear cells via a protein kinase C- and nitric oxide-dependent mechanism Endocrinology 144 2003 5595-5603
44. Boguszewski M. Dahlgren J. Bjarnason R. Rosberg S. Carlsson L.M.S. Albertssonwikland K. Serum leptin in short children born small for gestational age. Relationship with the growth response to growth hormone treatment Eur J Endocrinol 137 1997 387-395
45. Harigaya A. Nagashima K. Nako Y. Morikawa A. Relationship between concentration of serum leptin and fetal growth J Clin Endocrinol Metab 82 1997 3281-3284
46. Christou H. Connors J.M. Ziotopoulou M. Hatzidakis V. Papathanassoglou E. Ringer S.A. Mantzoros C.S. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth J Clin Endocrinol Metab 86 2001 935-938
47. Gat-Yablonski G. Ben-Ari T. Shtaif B. Potievsky O. Moran O. Eshet R. Maor G. Segev Y. Phillip M. Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth Endocrinology 145 2004 343-350
48. Matkovic V. Ilich J.Z. Skugor M. Badenhop N.E. Goel P. Clairmont A. Klisovic D. Nahhas R.H.W. Landoll J.D. Leptin is inversely related to age at menarche in human females J Clin Endocrinol Metab 82 1997 3239-3245
49. Roemmich J.N. Clark P.A. Mantzoros C.S. Gurgol C.M. Weltman A. Rogol A.D. Relationship of leptin to bone mineralization in children and adolescents J Clin Endocrinol Metab 88 2003 599-604
50. Dumond H. Presle N. Terlain B. Mainard D. Loeuille D. Netter P. Pottie P. Evidence for a key role of leptin in osteoarthritis Arthritis Rheum 48 2003 3118-3129
51. Ducy P. Amling M. Takeda S. Priemel M. Schilling A.F. Beil F.T. Shen J.H. Vinson C. Rueger J.M. Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass Cell 100 2000 197-207
52. Foldes J. Shih M.S. Levy J. Bone structure and calcium metabolism in obese Zucker rats Int J Obes 16 1992 95-102
53. Picherit C. Horcajada M.N. Mathey J. Chanteranne B. Puel C. Lebecque P. Davicco M.J. Coxam V. Barlet J.P. Isoflavone consumption does not increase the bone mass in osteopenic obese female Zucker rats Ann Nutr Metab 47 2003 70-77
54. Tamasi J.A. Arey B.J. Bertolini D.R. Feyen J.H.M. Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats J Bone Miner Res 18 2003 1605-1611
55. Takeda S. Elefteriou F. Levasseur R. Liu X. Zhao L. Parker K.L. Armstrong D. Ducy P. Karsenty G. Leptin regulates bone formation via the sympathetic nervous system Cell 111 2002 305-317
56. Elefteriou F. Takeda S. Liu X. Armstrong D. Karsenty G. Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass Endocrinology 144 2003 3842-3847
57. Baldock P.A. Sainsbury A. Couzens M. Enriquez R.F. Thomas G.P. Gardiner E.M. Herzog H. Hypothalamic Y2 receptors regulate bone formation J Clin Invest 109 2002 915-921
58. Cornish J. Callon K.E. Mountjoy K.G. Bava U. Lin J.M. Myers D.E. Naot D. Reid I.R. Alpha-melanocyte-stimulating hormone is a novel regulator o bone Am J Physiol Endocrinol Metab 284 2003 1181-1190
59. Pasco J.A. Henry M.J. Sanders K.M. Kotowicz M.A. Seeman E. Nicholson G.C. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study J Bone Miner Res 19 2004 19-24
60. Ghazali A. Grados F. Oprisiu R. Bunea D. Morinière P. el Esper N. Brazier M. Souberbielle J.C. Fournier A. Thomas T. Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients Nephrol Dial Transplant 18 2003 1882-1890
61. Matsunuma A. Kawane T. Maeda T. Hamada S. Horiuchi N. Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob/ob mice Endocrinology 145 2004 1367-1375
62. Elefteriou F. Takeda S. Ebihara K. Magre J. Patano N. Ae Kim C. Ogawa Y. Liu X. Ware S.M. Craigen W.J. et al. Serum leptin level is a regulator of bone mass Proc Natl Acad Sci U S A 101 2004 3258-3263